US Defence to press on with Immuron drug testing
The US Defence Department is to lodge an investigational new drug (IND) application with the Food and Drug Administration to press on with studies of Immuron’s novel treatment of gut pathogens. The DoD Naval Medical Research Centre (NMRC) has requested a meeting with the FDA for guidance on Phase 2 trials of the Melbourne drug…